Clinically-proven scalp therapy featuring plant-derived bio exosomes (Broccoli, Multiflora, Heartleaf) and multi-peptide complex. Demonstrated 89% DHT inhibition in HFDPC trials (J Dermatol Treat 2023), increasing hair density by 40% (±30 hairs/cm²) and shaft thickness by 60μm within 6 months. Medical-grade solution targeting 5 key alopecia pathways.

Advanced 3D Exosome Technology:
• Broccoli Exosomes (KGF activation)
• Multiflora Bioactives (Wnt pathway)
• 12-Peptide Matrix (BCL-2/Copper Tripeptide)
• Heartleaf Anti-Inflammatories

*Clinical results based on 142 participants in J Dermatol Treat 2023 study. Individual outcomes may vary depending on AGA stage, hormonal profile, and compliance with treatment protocol. Consultation with trichologist recommended prior to use.